Skip to content

Qigong for pre & stage 1 hypertension

Qigong for pre & stage 1 hypertension : A randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0001397
Enrollment
52
Registered
2015-02-27
Start date
2014-09-18
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Behavioral : Each qigong class lasts about 50 min, including 15-min warm-up and 10-min cool-down sessions.

Sponsors

Korea Institute of Oriental Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Men and women, aged 19 to 65 years 2. Blood pressure is in the prehypertension stage or at stage 1 hypertension (systolic blood pressure of 120-159 mmHg or diastolic blood pressure of 80-99 mmHg) (by the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure criteria) 3. Provide consent to participate in this trial and sign an informed consent statement

Exclusion criteria

Exclusion criteria: 1. Taking medicine for blood pressure control, such as prescription or over the counter drug or herb/supplements 2. Secondary hypertension 3. Previous cerebrovascular or heart disease such as myocardial infarction, angina and valvular disease 4. Wasting disease 5. Insulin or diabetes medication in diabetic patients 6. Previous kidney, liver or hyperthyroidism 7. Active tuberculosis and other infectious disease 8. Systemic steroids or immunosuppressive therapy 9. Oral contraceptives, central nervous system inhibitors or stimulants, such as taking medication that affects blood pressure 10. Pregnant women, lactating and pregnant women who plan on 11. Others whose clinical trials conductors are considered inappropriate for participating in this trial

Design outcomes

Primary

MeasureTime frame
The average systolic blood pressure

Secondary

MeasureTime frame
Measure Yourself Medical Outcome Profile 2 (MYMOP2);The average systolic blood pressure ;The average diastolic blood pressure ;Body mass index (BMI);Lipid profile;Adverse events;Quality of life (EuroQol-5 Dimension, EQ-5D)

Countries

Korea, Republic of

Contacts

Public ContactJung-hyo Cho

Daejeon University

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 27, 2026